294 related articles for article (PubMed ID: 30117265)
1. A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries PJ; Wilde L; de Vries MC; Moavero R; Pearson DA; Curatolo P
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):309-320. PubMed ID: 30117265
[TBL] [Abstract][Full Text] [Related]
2. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.
de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Kingswood JC; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
Orphanet J Rare Dis; 2018 Sep; 13(1):157. PubMed ID: 30201051
[TBL] [Abstract][Full Text] [Related]
3. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
[TBL] [Abstract][Full Text] [Related]
4. Is It Feasible to Identify Natural Clusters of TSC-Associated Neuropsychiatric Disorders (TAND)?
Leclezio L; Gardner-Lubbe S; de Vries PJ
Pediatr Neurol; 2018 Apr; 81():38-44. PubMed ID: 29530301
[TBL] [Abstract][Full Text] [Related]
5. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].
Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ
Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117
[TBL] [Abstract][Full Text] [Related]
6. The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.
Vanclooster S; Bissell S; van Eeghen AM; Chambers N; De Waele L; Byars AW; Capal JK; Cukier S; Davis P; Flinn J; Gardner-Lubbe S; Gipson T; Heunis TM; Hook D; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; Waltereit R; Jansen AC; de Vries PJ
J Neurodev Disord; 2022 Feb; 14(1):13. PubMed ID: 35151277
[TBL] [Abstract][Full Text] [Related]
7. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist.
de Vries PJ; Whittemore VH; Leclezio L; Byars AW; Dunn D; Ess KC; Hook D; King BH; Sahin M; Jansen A
Pediatr Neurol; 2015 Jan; 52(1):25-35. PubMed ID: 25532776
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric comorbidities in tuberous sclerosis complex patients with epilepsy: results of the TAND checklist survey.
Lee HY; Lin CH; Wang XA; Tsai JD
Acta Neurol Belg; 2024 Jun; 124(3):973-979. PubMed ID: 38523222
[TBL] [Abstract][Full Text] [Related]
9. Natural clusters of tuberous sclerosis complex (TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project.
de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; D'Amato L; Beure d'Augères G; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC; Jansen AC;
J Neurodev Disord; 2020 Sep; 12(1):24. PubMed ID: 32873244
[TBL] [Abstract][Full Text] [Related]
10. Assessment of tuberous sclerosis-associated neuropsychiatric disorders using the MINI-KID tool: a pediatric case-control study.
Ding Y; Wang J; Zhou H; Li T; Zhou S; Wang Y
Orphanet J Rare Dis; 2021 Apr; 16(1):181. PubMed ID: 33865427
[TBL] [Abstract][Full Text] [Related]
11. Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study.
Toldo I; Brasson V; Miscioscia M; Pelizza MF; Manara R; Sartori S; Mantegazza G; Vecchi M; Nosadini M; Gatta M
Dev Med Child Neurol; 2019 Feb; 61(2):168-173. PubMed ID: 30298907
[TBL] [Abstract][Full Text] [Related]
12. Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype.
de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; Beaure d'Augères G; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Kingswood JC; Jansen AC;
Front Neurol; 2020; 11():603. PubMed ID: 32733359
[No Abstract] [Full Text] [Related]
13. International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries PJ; Heunis TM; Vanclooster S; Chambers N; Bissell S; Byars AW; Flinn J; Gipson TT; van Eeghen AM; Waltereit R; Capal JK; Cukier S; Davis PE; Smith C; Kingswood JC; Schoeters E; Srivastava S; Takei M; Gardner-Lubbe S; Kumm AJ; Krueger DA; Sahin M; De Waele L; Jansen AC
J Neurodev Disord; 2023 Sep; 15(1):32. PubMed ID: 37710171
[TBL] [Abstract][Full Text] [Related]
14. Tuberous Sclerosis Complex Patients' Needs and Difficulties-Results of TAND Questionnaire Analysis in Polish Adult Population.
Marcinkowska AB; Jóźwiak S; Tarasewicz A; Dębska-Ślizień A; Szurowska E
J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362764
[TBL] [Abstract][Full Text] [Related]
15. Symptom rates and profile clustering in tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
Alperin S; Krueger DA; Franz DN; Agricola KD; Stires G; Horn PS; Capal JK
J Neurodev Disord; 2021 Dec; 13(1):60. PubMed ID: 34903167
[TBL] [Abstract][Full Text] [Related]
16. Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist.
Leclezio L; Jansen A; Whittemore VH; de Vries PJ
Pediatr Neurol; 2015 Jan; 52(1):16-24. PubMed ID: 25499093
[TBL] [Abstract][Full Text] [Related]
17. Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders and Parental Stress: Findings from a National, Prospective TSC Surveillance Study.
Ebrahimi-Fakhari D; Hussong J; Flotats-Bastardas M; Ebrahimi-Fakhari D; Zemlin M; von Gontard A; Meyer S
Neuropediatrics; 2019 Oct; 50(5):294-299. PubMed ID: 31266065
[TBL] [Abstract][Full Text] [Related]
18. Involvement of mental health professionals in the treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): results of a multinational European electronic survey.
Waltereit R; Beaure d'Augères G; Jancic J; Kingswood JC; Koleva M; Marques R; Villanueva V; Auvin S
Orphanet J Rare Dis; 2021 May; 16(1):216. PubMed ID: 33980296
[TBL] [Abstract][Full Text] [Related]
19. New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND).
Gipson TT; Johnston MV
F1000Res; 2017; 6():. PubMed ID: 28663780
[TBL] [Abstract][Full Text] [Related]
20. Behavioral problems and family distress in tuberous sclerosis complex.
Uematsu M; Numata-Uematsu Y; Aihara Y; Kobayashi T; Fujikawa M; Togashi N; Shiihara T; Ohashi K; Hattori A; Saitoh S; Kure S
Epilepsy Behav; 2020 Oct; 111():107321. PubMed ID: 32698109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]